Trial0

Clinical trial · NCT06021704

The Care for America's Aging Study

Not yet recruiting

Sponsor: Massachusetts General Hospital

We save this real registry record and notify you if its published status changes. Create an account to add profile details that improve future matching.

Summary

Care for America's Aging is a randomized pilot study investigating whether a home health aide training intervention consisting of enhanced dementia-specific curriculum content will improve: 1) behavioral symptoms of older adult persons living with dementia or cognitive impairment (PLWD/CI) and 2) global health-related quality of life among PLWD/CI and their care partners.

Interventions

  • Enhanced home health aide training in dementia and dementia-related behaviors · BEHAVIORAL

    8 hours (2 instructional days) of enhanced curriculum dementia-specific instruction for home health aides

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria for Patients:

* Age 60 years and above
* Patients in Mass General Brigham healthcare system
* Mild cognitive impairment or dementia diagnosis of no greater than mild-moderate severity
* Discharge plan includes referral to home care services
* As all surveys have been validated in English, we will limit participation to potential participants able to read English.

Exclusion Criteria for Patients:

* Discharge to Medicare short-term rehab only
* Lack of care partner
* Enrolled in palliative care (projected survival \< 6 months)
* Clinical severity of dementia that is moderate or greater
* Any active clinical issues barring safe participation
* Montreal Cognitive Assessment (MoCA)-blind score below cutoff
* University of California, San Diego Brief Assessment of Capacity to Consent (UBACC) score below cutoff

Sites (1)

  • Massachusetts General Hospital, Boston, Massachusetts

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2026-07-06.